BARE LYMPHOCYTIC SYNDROME TYPE I DUE TO TAP2 MUTATION IN AN 18-YEAR-OLD MALE- A CASE REPORT
- Professor and Medical Superintendent Department of General Medcine Vinayaka Missions Kirupananda Variyar Medical College and Hospitals Vinayaka missions research foundation (DU ) Salem.
- Postgraduate Resident, MD General Medicine Vinayaka Missions Kirupananda Variyar Medical College and Hospitals Vinayaka missions research foundation (DU ) Salem.
- Professor Department of General Medcine Vinayaka Missions Kirupananda Variyar Medical College and Hospitals Vinayaka missions research foundation (DU ) Salem.
0 Downloads
4 Views
Abstract
Bare lymphocyte syndrome type I (BLS I) is a rare autosomal recessive primary immunodeficiency caused by defective major histocompatibility complex class I expression due to abnormalities in antigen-processing pathways. We report an 18-year-old male with recurrent respiratory infections, bilateral bronchiectasis, vasculitic skin ulcers, severe malnutrition, and neurological manifestations, including previous varicella zoster encephalopathy. Whole exome sequencing identified a homozygous TAP2 splice-site mutation (c.1272+1del), confirming BLS I. The patient was managed with antimicrobial therapy, nutritional rehabilitation, and supportive care. This case highlights the importance of considering underlying primary immunodeficiency disorders in patients presenting with recurrent respiratory infections and multisystem inflammatory manifestations.
Keywords
How to Cite This Article
Dr Seetharaman Ranganathan Rangabashyam et, al (2026); BARE LYMPHOCYTIC SYNDROME TYPE I DUE TO TAP2 MUTATION IN AN 18-YEAR-OLD MALE- A CASE REPORT, International Journal of Advanced Research (IJAR), 14 (08), 724-730, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/23995
Corresponding Author
Publication Achievement
Publication card
🎉 Proud to contribute to scientific research! Share your publication with your colleagues and professional network.
Article Analytics
This work is licensed under a Creative Commons Attribution 4.0 International License.





